Alan Shuler - ProUroCare Medical CFO and Secretary
CFO
Mr. Alan G. Shuler was appointed as Chief Financial Officer, Secretary of Prourocare Medical Inc., effective May 17, 2013. Mr. Shuler has over 30 years of Senior Financial Executive experience including 3 years as Senior VP and CFO of FSI International, 12 years as VP and CFO of Datakey, Inc. and 6 years as CEO of the financial services unit of Carlson Companies, Inc. For the past 9 years Mr. Shuler was Principal of Shuler Associates, a consulting firm specializing in Interim CFO assignments and a variety of SEC reporting projects. since 2013.
| Age | 75 |
| Tenure | 12 years |
| Phone | 952-476-9093 |
| Web | http://www.prourocare.com |
ProUroCare Medical Management Efficiency
The company has return on total asset (ROA) of (0.6095) % which means that it has lost $0.6095 on every $100 spent on assets. This is way below average. ProUroCare Medical's management efficiency ratios could be used to measure how well ProUroCare Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | CFO Age | ||
| Peter Juhas | AerCap Holdings NV | 52 | |
| Alexandra Brooks | Hertz Global Hldgs | 53 | |
| Nathaniel CPA | MGIC Investment Corp | 41 | |
Management Performance
| Return On Asset | -0.61 |
ProUroCare Medical Leadership Team
Elected by the shareholders, the ProUroCare Medical's board of directors comprises two types of representatives: ProUroCare Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ProUroCare. The board's role is to monitor ProUroCare Medical's management team and ensure that shareholders' interests are well served. ProUroCare Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ProUroCare Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stanton Myrum, CEO and Director | ||
| RAC JD, Consultant | ||
| Alan Shuler, CFO and Secretary | ||
| David MD, Consultant |
ProUroCare Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ProUroCare Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.61 | |||
| Current Valuation | 1.73 M | |||
| Shares Outstanding | 18.6 M | |||
| Price To Earning | (0.05) X | |||
| EBITDA | (462.3 K) | |||
| Net Income | (2.96 M) | |||
| Cash And Equivalents | 970 | |||
| Current Ratio | 0.06 X | |||
| Book Value Per Share | (0.22) X | |||
| Cash Flow From Operations | (1.12 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in ProUroCare Stock
If you are still planning to invest in ProUroCare Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ProUroCare Medical's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |